Skin autofluorescence predicts major adverse cardiovascular events in patients with type 1 diabetes: a 7-year follow-up study

Table 2 Risk of major adverse cardiovascular event over the follow-up according to SAF at baseline

	HR	95% Confidence interval	p
SAF (per 1 AU)	4.13	1.30; 13.07	0.02
Sex
Men	4.15	0.87; 19.77	0.07
BMI (per 1 kg/m²)	1.11	0.96; 1.27	0.16
MACE at baseline
Yes	3.01	0.99; 9.08	0.05
Statins baseline
Yes	2.55	0.77; 8.47	0.13
eGFR (mL/min)
< 60	1.54	0.32; 7.31	0.59
Albumin excretion rate (mg/24 h)
≥ 30	1.92	0.54; 6.88	0.32
Hypertension
Yes	2.70	0.61; 11.98	0.19
Diabetes duration in 2009 (per 1 year)	1.02	0.98; 1.06	0.38

ISSN: 1475-2840